Cheap pandemic-era debt is turning toxic. As borrowing costs surge, hundreds of U.S. firms can no longer cover interest payments, raising the specter of “corporate zombies.” Intrasia Wealth examines what’s driving this trend, the risks for investors, and how disciplined credit selection can turn volatility into opportunity.

October saw risk assets climb as a tentative US–China trade truce and moderating inflation bolstered optimism. The Fed’s measured tone and resilient earnings supported equities, though valuations remain stretched.